Uri A Lopatin
CIK 1613259 · President and CEO · last filed 2023-08-31
Uri A Lopatin is a President and CEO who has filed 9 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for PRDS, was dated Aug 31, 2023. Across all open-market trades the lifetime net is −$623.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.38M
3
9
-$623.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | President and CEO | 0 | $2.16 | $0 | $0 | 3 | 2023-08-31 |
| ASMB | Chief Medical Officer | 52,697 | $26.21 | $1.38M | -$623.0K | 5 | 2019-04-02 |
| ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted | Chief Med. Off., VP Res. Dev. | 621,651 | — | — | $0 | 1 | 2014-07-14 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-31 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Mixed | −5,679,746 | $0 | EDGAR |
| 2023-06-02 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-02 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-02 | ASMB | Grant (A) | +13,750 | $0 | EDGAR |
| 2018-09-07 | ASMB | Sell (S) | −15,540 | -$623.0K | EDGAR |
| 2018-03-30 | ASMB | Grant (A) | +7,500 | $0 | EDGAR |
| 2017-03-31 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2014-10-07 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2014-07-14 | ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.